
بیوتیک
آنتي بيوتيك سازي ايران
تریدر | نوع سیگنال | حد سود/ضرر | زمان انتشار | مشاهده پیام |
---|---|---|---|---|
![]() واچ لیست ممتاز رایگان💚Rank: 453 نیاز به اشتراک | خرید | حد سود: تعیین نشده حد ضرر: تعیین نشده نیاز به اشتراک | 5/31/2025 | نیاز به اشتراک |
MohammadrezamobaseriRank: 3366 نیاز به اشتراک | خرید | حد سود: ۳۶٬۰۰۰ حد ضرر: ۲۲٬۵۰۰ نیاز به اشتراک | 8/31/2025 | نیاز به اشتراک |
![]() زیبا سرشت - کریم زادهRank: 3215 نیاز به اشتراک | خرید | حد سود: تعیین نشده حد ضرر: تعیین نشده نیاز به اشتراک | 8/18/2025 | نیاز به اشتراک |
M.abiri_66Rank: 3426 | خرید | حد سود: ۳۳٬۸۰۷ حد ضرر: تعیین نشده | 5/7/2025 | |
![]() شرکت سرمایه گذاری داروئی تامینRank: 3133 | خرید | حد سود: تعیین نشده حد ضرر: تعیین نشده | 6/24/2024 |
Adjusted Price Chart of بیوتیک and بیوتیک Signal Trend
سود 3 Months :
Who made the most profit from بیوتیک?

Trader18
شرکت سبدگردان سورین

mehdi998.ir

قادر باغچیقی

homa880088
سیگنالهای بیوتیک
Filter
Signal Type
Trader Type
Time Frame
نوع پیام

بورسی های گیلان
#Medication (2) monthly ❇️ 5 months performance to 5 months 403 (Billion USD) ●#Dajabar income [602 MT] 6% drop ●#Biotics Income [742 MT] Growth 23% Growth ● #Darm Revenue [432 MT] Growth 40% ●#Income Revenue [503 MT] Growth 32% ●#Dekimi Income [394 MT] Growth 48% Growth ●#KBC Revenue [268m] Growth 307% ●#Long revenue [4,980mm] 2% drop ●#Claimer Income [826 MT] Growth 121% ●#Disaster Revenue [963 MT] Growth 42% Growth ●#Dabor Revenue [1,410 MT] Growth 55% ●#Daine of Income [158m] Growth 41% ●#24% Growth Income [484 MT] ●#53% growth in revenue [583 MT] ●#Lolk Income [941m] Growth 67% ●#Deanco Income [249 MT] Growth 9% Growth ●#Delibal Revenue [449 MT] Growth 84% Growth ●#Dasouh Revenue [341m] 12% Growth ●#Druz income [182m] 15% drop ●#Income Income [333m] Growth 71% ●#Di in Revenue [293 MT] Growth 35% Growth
Mohammadrezamobaseri

Biotics Ascending trend Good Foundation Due to the activation of the trigger mechanism and the problems in the pharmaceutical industry and the increase in potential prices was a positive profit process. Be purchased in a few steps

زیبا سرشت - کریم زاده
Buy biotics ....

زیبا سرشت - کریم زاده
I have been discussing biotics in the past few days, which was shown to be a share of the share .... Today is a purchase queue.

زیبا سرشت - کریم زاده
Biotics are more likely to be corrected at these prices than ... with this share more share than the fluctuation .....

زیبا سرشت - کریم زاده
Biotics also reached positive prices at the border of sales. And has a good shock

💰کلوپ مالی بورس 💎
108% of the price growth profit last year was for #biotics @alihadaf_bours Www.alihadaf.com The reversal process and the new structure of the specified areas were formed

صندوق سرمایه گذاری بخشی صنایع مفید -دارونو
Investment Fund for useful industries -Darono bought 0.090 million shares of biotics on 14/05/12 and currently holds 1.71 % of biotic shares in its equity portfolio.

صندوق سرمایه گذاری بخشی صنایع مفید -دارونو
The Investment Fund for useful industries -Darono bought 0.121 million biotic shares on 14/05/11 and currently holds 1.699 % of biotics in its portfolio portfolio.

نرم افزار تحلیل گر بورس - دایموند
#Group sales report #medicine In June 1404, pharmaceutical companies sold 17467 billion tomans, which increased by 40 % compared to the same year last year. 💵 Export sales of 204 billion tomans, which increased by 5 % compared to the same year. #Dezagress Company registered the highest export with 124 billion USD. ✅ #Broadcasting Company with the highest sales of 3503 billion USD had the highest sales. The following companies recorded the highest growth rate compared to the same year. #Dafra 148% #Dalk 137%🔥 #102% Long #Caspian 97% #87% medicine #Damidid 82%🔥 #82%Demeravi #75% Broadcast #72% Daller #66% #60% Dignity #59% #53% decay #Decoration 52%🔥 #48% Deanko #47%🔥 #Depars 46%🔥 #46% Dukimi #44% dendina #41% difficulty #Deller 29% #29% detection #27% Dabor #Defense 25% #21% biiotic #19% Hijra #Dasou 17% #16% late #2% 📅 Last Update: 1404/04/20 Support the capital market by submitting this report in groups and stock markets; 🇮🇷@dndir
Disclaimer
Any content and materials included in Sahmeto's website and official communication channels are a compilation of personal opinions and analyses and are not binding. They do not constitute any recommendation for buying, selling, entering or exiting the stock market and cryptocurrency market. Also, all news and analyses included in the website and channels are merely republished information from official and unofficial domestic and foreign sources, and it is obvious that users of the said content are responsible for following up and ensuring the authenticity and accuracy of the materials. Therefore, while disclaiming responsibility, it is declared that the responsibility for any decision-making, action, and potential profit and loss in the capital market and cryptocurrency market lies with the trader.